PLACE LABEL HERE ASPIRIN DESENSITIZATION ORDERS for Aspirin Related Urticaria / Angioedema The following orders will be implemented. Orders with a “” are choices and are NOT implemented unless checked. Initial all handwritten order modifications and the bottom of each page when indicated (multipage). 1. Unit: Transfer patient to ICU setting and must remain for 2 hrs post completion of this protocol 2. Assessment/Monitoring: Obtain baseline and document assessment with each new dose Observe for hypersensitivity reactions and document if the patient has the following: itching, rash, wheezing, dyspnea, rhinorrhea Blood pressure and pulse Oxygen Saturation 3. Hold beta-blocker dose prior to desensitization to avoid blunting reaction response 4. Pharmacy Preparation: Aspirin Suspension Bottle A: (Aspirin 1 mg/ml) Crush and dissolve Aspirin 81 mg chewable aspirin tablet into 81 ml tap water Label bottle A Aspirin Suspension Bottle B: (Aspirin 0.1 mg/ml) Remove 1 ml from Aspirin suspension Bottle A and add to 9 ml tap water Label bottle B Pharmacy to dispense each dose in a labeled oral syringe 5. Aspirin Desensitization Dosing: 81 mg 162 mg 325 mg (see dose chart below to achieve aspirin dose goal) Goal dose depends on Aspirin dose that patient is expected to take long term. Goal Aspirin Oral dose Dose 1 Dose 2 Dose 3 Dose 4 Dose 5 Dose 6 Dose 7 Dose 8 **Dose 9 **Dose 10 0 minutes 20 min 40 min 60 min 80 min 100 min 120 min 140 min 160 min 180 min 0.1 mg 0.3 mg 1 mg 3 mg 10 mg 30 mg 40 mg 81 mg 162 mg 325 mg Give 1 ml po of Bottle B Give 3 ml po of Bottle B Give 1 ml po of Bottle A Give 3 ml po of Bottle A Give 10 ml po of Bottle A Give 30 ml po of Bottle A Give 40 ml po of Bottle A Give 81 mg chewable tablet po Give 2 x 81 mg chewable tablets po Give 4 x 81 mg chewable tablets po ** Optional doses that may be administered, depends on goal Aspirin dose PRN MEDICATIONS: 6. Anaphylaxis: Epinephrine 0.3-0.5 ml, 1:1000 (1 mg/ml) solution IM q 5 min prn in absence of clinical improvement ADDITIONAL ORDERS: 7. Notify physician if patient develops signs of allergic reaction ______________ Date ______________ Time *1-38389* ________________________________ Physician Signature FORM 1-38389 INITIATED 05/2015 ___________ PID Number Page 1 of 1